V004-3762 Screening compound: N~1~-allyl-4-[2-methyl-8-(trifluoromethyl)dibenzo[b,f][1,4]oxazepin-11-yl]tetrahydro-1(2H)-pyrazinecarboxamide

V004-3762 Screening compound: N~1~-allyl-4-[2-methyl-8-(trifluoromethyl)dibenzo[b,f][1,4]oxazepin-11-yl]tetrahydro-1(2H)-pyrazinecarboxamide
V004-3762 Screening compound: N~1~-allyl-4-[2-methyl-8-(trifluoromethyl)dibenzo[b,f][1,4]oxazepin-11-yl]tetrahydro-1(2H)-pyrazinecarboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V004-3762
N~1~-allyl-4-[2-methyl-8-(trifluoromethyl)dibenzo[b,f][1,4]oxazepin-11-yl]tetrahydro-1(2H)-pyrazinecarboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V004-3762

Molecular Formula

C23H23F3N4O2 (C23 H23 F3 N4 O2)

Compound Name

N~1~-allyl-4-[2-methyl-8-(trifluoromethyl)dibenzo[b,f][1,4]oxazepin-11-yl]tetrahydro-1(2H)-pyrazinecarboxamide

IUPAC name

4-[13-methyl-6-(trifluoromethyl)-2-oxa-9-azatricyclo[9.4.0.0^{38}]pentadeca-1(11)35791214-heptaen-10-yl]-N-(prop-2-en-1-yl)piperazine-1-carboxamide

SMILES

Cc(cc1)cc2c1Oc(ccc(C(F)(F)F)c1)c1N=C2N(CC1)CCN1C(NCC=C)=O

InChI

InChI=1S/C23H23F3N4O2/c1-3-8-27-22(31)30-11-9-29(10-12-30)21-17-13-15(2)4-6-19(17)32-20-7-5-16(23(24,25)26)14-18(20)28-21/h3-7,13-14H,1,8-12H2,2H3,(H,27,31)

InChI Key

SBWCYEIKWUNZCP-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14284109

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

444.46

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.917

Distribution Coefficient, logD

3.219

Water Solubility, LogSw

-4.08

Polar Surface Area

44.974

Acid Dissociation Constant (pKa)

15.19

Base Dissociation Constant (pKb)

8.00

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

30.43

V004-3762 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
Targets:
  • Kinases
  • Others
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with V004-3762 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V004-3762?
Check Price and Availability of V004-3762, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V004-3762 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V004-3762
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V004-3762
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V004-3762 available by request